Analyst Ratings for Pluristem Therapeutics (PSTI)

PSTI Rating Summary

  |   Expand Research on PSTI
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: N/A
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
9/16/2013 Maxim Group Upgrade Buy
(Hold)
N/A
(N/A)
3.22 2.83 -12.11% Details
5/31/2013 MLV & Co. New Coverage Buy
(N/A)
4.50
(N/A)
3.14 2.83 -9.87% Details
Like PSTI Ratings? Also take a look at NURO, NRX, NVTL, NG

PSTI Ratings News